However, the combination of an AXL-targeting treatment with the existing standards of care, such as radio-chemotherapy, should be further explored in patients that are AXL-positive or present with lymph node metastases to prevent further disease progression and to offer novel therapeutic options. The gene discussed is AXL; the disease is metastatic malignant neoplasm in the lymph nodes.